A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy

Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases. The main indication for NB-UVB and PUVA therapies is psoriasis, and other key diagnoses include atopic eczema, vitiligo, cutaneous T-cell lymphoma (CTCL), and the photodermatoses. The decision on choice of phototherapy is important and NB-UVB is usually the primary choice. NB-UVB phototherapy is a safe and effective therapy which is usually considered when topical agents have failed. PUVA requires prior psoralen sensitization but remains a highly effective mainstay therapy, often used when NB-UVB fails, there is rapid relapse following NB-UVB or in specific indications, such as pustular or erythrodermic psoriasis. This review will provide a perspective on the main indications for use of NB-UVB and PUVA therapies and provide comparative information on these important dermatological treatments

Cytomegalovirus-associated splenic infarcts in a female patient with Factor V Leiden mutation: a case report

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Biological treatment for bullous pemphigoid

BackgroundBullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease. Topical or systemic corticosteroids are often used as the first-line treatment. However, long-term corticosteroid use may lead to significant side effects. Therefore, various adjuvant immunosuppressant therapies are used as steroid-sparing agents, with accumulating reports of biological treatments for severely recalcitrant BP.ObjectiveTo describe the clinical and immunological features of a series of patients with recalcitrant BP treated with immunobiological therapies. To assess the efficacy and safety of their therapies.MethodsPatients receiving biological treatment for BP from two centers were assessed. Here, we described the clinical, immunopathological, and immunofluorescence findings of adult patients with BP and analyzed the clinical response and adverse events associated with various biological therapies.ResultsWe identified nine eligible patients treated with rituximab (seven), omalizumab (three), or dupilumab (one). The mean age at diagnosis was 60.4 years, the average BP duration before biologic initiation was 1.9 years, and the average previous treatment failure was 2.11 therapies. The mean follow-up period from the first biological treatment to the last visit was 29.3 months. Satisfactory response, defined as clinical improvement, was achieved in 78% (7) of the patients, and total BP clearance was achieved in 55% (5) of the patients at the last follow-up visit. Additional rituximab courses improved the disease outcomes. No adverse events were reported.ConclusionsEfficient and safe novel therapies can be considered in recalcitrant steroid-dependent BP non-responsive to conventional immunosuppressant therapies

The pseudo‐brookite spin‐glass system studied by means of muon spin relaxation

Zero-field muon spin relaxation (µSR) experiments have been performed on the spin glass Fe1.75Ti1.25O5. Above the spin-glass temperature of 44 K a distinct exponential µSR rate (¿) is observed, while below Tg a square-root exponential decay occurs, indicating fast spin fluctuations. Near 8 K, a maximum in ¿ is indicative of transverse spin ordering. The low ¿ values and the sharp ¿ peak at Tg are very promising for the study of spin freezing models like the Vogel–Fulcher law or the power law

Therapeutic potential of enoxaparin in lichen planus: Exploring reasons for inconsistent reports

Lichen planus (LP) is an uncommon mucocutaneous inflammatory condition, that is immunologically mediated, typically pruritic and often recurs. The currently advocated therapies are either not highly effective or associated with severe side effects. Enoxaparin, a widely used anticoagulant, is composed of both anticoagulant and non-anticoagulant fragments. Enoxaparin is reported to have anti-inflammatory properties and it was found to be effective in LP. However, the results from clinical studies have varied substantially and, therefore, the clinical role of enoxaparin in LP remains uncertain. This review focuses on potential reasons for the reported inconsistent outcomes, as well as proposing solutions; these include identifying batch-to-batch inconsistency in the composition of enoxaparin. The potential therapeutic value of enoxaparin in LP must be explored using well-designed clinical trials, combined with experimental studies that focus on identifying the anti-inflammatory fragments of enoxaparin and elucidating the mechanism of action of these non-anticoagulant fragments

Magnetic anisotropy in the cubic Laves REFe2 intermetallic compounds

In the past, the Callen–Callen (1965 Phys. Rev. 139 A455–71; 1966 J. Phys. Chem. Solids 27 1271–85) model has been highly successful in explaining the origin and temperature dependence of the magneto-crystalline anisotropy in many magnetic compounds. Yet, despite their high ordering temperatures of ~650 K, the Callen–Callen model has proved insufficient for the REFe2 compounds. In this paper, we show that it is possible to replicate the values of the phenomenological parameters K1, K2, and K3 given by Atzmony and Dariel (1976 Phys. Rev. B 13 4006–14), by extending the Callen–Callen model to second order in HCF. In particular, explanations are provided for (i) the unexpected changes in sign of K1 and K2 in HoFe2 and DyFe2, respectively, and (ii) the origin and behaviour of the K3 term. In addition, it is demonstrated that higher order terms are required, and that K4 exceeds K3 at low temperatures. Revised estimates of K1, K2, K3, K4, and K5 are given. Finally, an alternative 'multipolar' approach to the problem of magnetic anisotropy is also provided. It is shown that the latter confers significant advantages over the older phenomenological method. In particular, all the multipolar coefficients (\tilde {K}_N , N = 4, 6, 8, 10, 12) decrease monotonically with increasing temperature, with \tilde {K}_N decreasing faster than \tilde {K}_{N-2} etc. These observations are in accord with expectations based on the original Callen–Callen model